Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Drugmakers and PBMs Disagree Over 340B Contracts, Discounts and Patient Benefit
Summary
Drugmakers told lawmakers that the federal 340B discount program for safety‑net providers has expanded and, in some cases, been routed through contract pharmacies in ways that do not reduce patient cost sharing. Manufacturers and PBMs gave different accounts of whether discounts reached patients.
COLUMBIA, S.C. — Witnesses told a legislative committee that the federal 340B program — created to give safety‑net hospitals and clinics discounts on outpatient drugs — has expanded and become intertwined with contract pharmacies and PBM practices in ways that complicate who gets discounts and whether patients benefit.
What witnesses said: Scott White of Johnson & Johnson told the committee that manufacturers provided large discounts to 340B covered entities, and he expressed concerns that contract pharmacy arrangements and extensive use of 340B by large hospital systems…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
